AbbVie Equity Dashboard

ABBV -- USA Stock  

USD 98.25  0.24  0.24%

The AbbVie Equities Center is a collection of modules for AbbVie equity research and analysis. Using equity center you examine different market driven as well as company specific characteristics using powerful technical, fundamental, predictive and other AbbVie specific modules. Please select from the options below.
Quote & Profile

Quote & Profile

AbbVie profile, quote, and daily performance
Earnings Buzz

Earnings Buzz

Historical and projected earnings estimates for AbbVie
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for AbbVie
Event Calendar

Event Calendar

Calendar of corporate events and headlines for AbbVie
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for AbbVie
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for AbbVie
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for AbbVie
Chance of Bankruptcy

Chance of Bankruptcy

AbbVie chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different AbbVie historical pattern-recognition indicators
Current Valuation

Current Valuation

AbbVie valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

AbbVie current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze AbbVie Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

AbbVie volatility and risk analysis compared to market
Correlation With Market

Correlation With Market

AbbVie correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

AbbVie in the context of related companies
Management

Management

AbbVie leadership and management evaluation
Performance

Performance

Risk adjusted expected returns and performance analysis
Risk-adjusted Recommendation

Risk-adjusted Recommendation

Personalized buy or sell advice on AbbVie
Power Widgets

Power Widgets

Macroaxis widgets syndication for AbbVie
Price Prediction

Price Prediction

Basic AbbVie price forecast based on headlines and hype
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for AbbVie
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of AbbVie
Fundamental History

Fundamental History

AbbVie history of fundamentals from various financial
Revenue

Revenue

Relative AbbVie revenue analysis
Net Income Analysis

Net Income Analysis

AbbVie income analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on AbbVie operations
Price History

Price History

AbbVie daily price history and news impact
Pair Correlation

Pair Correlation

Correlation analysis between AbbVie and Vertex Pharmaceuticals
ABBV vs. ENDP

ABBV vs. ENDP

Fundamentals comparison between AbbVie and Endo International
This is a quick snapshot of AbbVie research areas. You can expand your research by examining different market driven as well as company specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and and many other powerfull tools.

Portfolio Quick Statement

Portfolio Postitions Statement
Check portfolio thematic classification for all positions as well as asset allocations via different sub-views such as market cap, equity types, industries and sectors.
Analyze Portfolio Positions  
Current Thematic Trending
Manufacturing
Purchased over 100 shares
Traded six days ago for 10.44
Manufacturing
Purchased over 300 shares
Traded six days ago for 6.24
Investor Favorites
Purchased over 70 shares
Traded six days ago for 23.42
Agribusiness Agriculture And Fishing
Purchased over 200 shares
Traded six days ago for 8.1
Manufacturing
Purchased over 400 shares
Traded six days ago for 4.74
Manufacturing
Purchased over 500 shares
Traded six days ago for 3.42